Abbott Laboratories v. Mylan Pharmaceuticals, Inc.

528 U.S. 1181, 120 S. Ct. 1220, 145 L. Ed. 2d 1120, 68 U.S.L.W. 3535, 2000 U.S. LEXIS 1429
CourtSupreme Court of the United States
DecidedFebruary 22, 2000
DocketNo. 99-1032
StatusPublished

This text of 528 U.S. 1181 (Abbott Laboratories v. Mylan Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abbott Laboratories v. Mylan Pharmaceuticals, Inc., 528 U.S. 1181, 120 S. Ct. 1220, 145 L. Ed. 2d 1120, 68 U.S.L.W. 3535, 2000 U.S. LEXIS 1429 (2000).

Opinion

C. A. Fed. Cir. Certiorari denied.

Justice O’Connor took no part in the consideration or decision of this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
528 U.S. 1181, 120 S. Ct. 1220, 145 L. Ed. 2d 1120, 68 U.S.L.W. 3535, 2000 U.S. LEXIS 1429, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abbott-laboratories-v-mylan-pharmaceuticals-inc-scotus-2000.